FeCr matrix high-temperature self-lubricating composites reinforced by Mo, Ag, and CuO were fabricated by the powder metallurgy technique. The tribological behaviors of composites were studied at temperatures up to 800 °C. The CuO content was optimized according to the tribological results. Mo showed an obvious lubricating effect when it converted into MoO. The bimetallic oxide system formed high-temperature solid lubricants with low shear strength. CuO reacted with MoO and formed CuMoO and CuMoO. The composites showed an increase in the friction coefficient with the increase of CuO. However, the wear rates decreased with the increase of CuO. The critical threshold at which there was a transition of friction coefficients and wear rates from room temperature (RT) to 800 °C was 10 wt.% CuO. The Fe(Cr)-14% Mo-10.5% Ag-10% CuO composite showed the most reasonable high-temperature tribological behaviors. This was ascribed to the synergistic effects of silver, Mo, in situ formed solid lubricants (metal oxides and salt compounds), and the stable oxide film on the worn surfaces. At elevated temperatures, the dominant wear mechanism was oxidation wear.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981401PMC
http://dx.doi.org/10.3390/ma13010051DOI Listing

Publication Analysis

Top Keywords

800 °c
12
fecr matrix
8
self-lubricating composites
8
room temperature
8
temperature 800
8
tribological behaviors
8
solid lubricants
8
increase cuo
8
wear rates
8
cuo
7

Similar Publications

Article Synopsis
  • Atherosclerotic cardiovascular disease has a high mortality rate linked to vascular calcification, with fetuin-A's role in aortic arch calcification (AAC) not fully understood.
  • An analysis of 800 individuals revealed that those with AAC had higher blood pressure and lower fetuin-A levels, indicating a connection between these factors.
  • The findings suggest that low fetuin-A levels and high systolic blood pressure can more accurately predict AAC, highlighting the importance of these biomarkers in cardiovascular health.
View Article and Find Full Text PDF

Background: Abdominal aortic calcification (AAC) pathogenesis is intricately linked with inflammation. The pan-immune-inflammation value (PIV) emerges as a potential biomarker, offering reflection into systemic inflammatory states and assisting in the prognosis of diverse diseases. This research aimed to explore the association between PIV and AAC.

View Article and Find Full Text PDF

The structural changes that accompany the dehydration of NaPtX·6HO (X = Cl, Br) were studied using in situ variable temperature synchrotron X-ray diffraction. The two hexahydrates are isostructural, containing isolated Pt octahedra separated by Na cations. Removal of the water results in the formation of the anhydrous vacancy ordered double perovskites NaPt.

View Article and Find Full Text PDF

Background: Pemetrexed is an efficacious multi-targeted antifolate with acceptable toxicity for non-squamous non-small cell lung cancer (non-Sq NSCLC) and malignant pleural mesothelioma. Vitamin B12 and folic acid as premedication can reduce the frequency of severe toxicities of pemetrexed chemotherapy. However, adverse effects are frequent in clinical settings.

View Article and Find Full Text PDF

Introduction: Parathyroid hormone-lowering responses after administration of three different therapies capable of raising serum total 25-hydroxyvitamin D (25OHD) were evaluated in patients with secondary hyperparathyroidism (SHPT), vitamin D insufficiency (VDI), and stage 3 or 4 chronic kidney disease (CKD).

Methods: Sixty-nine adult subjects with intact parathyroid hormone (iPTH) ≥85 and <500 pg/mL and VDI (25OHD <30 ng/mL) were randomized after ≥4-week washout to 2 months of open-label treatment with: (1) extended-release calcifediol (ERC) 60 μg/day; (2) immediate-release calcifediol (IRC) 266 μg/month; (3) high-dose cholecalciferol (HDC) 300,000 IU/month; or (4) paricalcitol plus low-dose cholecalciferol (PLDC) 1 or 2 μg and 800 IU/day, used as reference hormone replacement therapy. Serum 25OHD, calcium (Ca), phosphorus (P), plasma iPTH, and adverse events were monitored weekly.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!